Zohar Barbash
Chief Technology Officer Lembas
Dr. Zohar Barbash, PhD (Tel Aviv University; post-doc at NCI/NIH), is co-founder and CTO of Lembas, where she merges bioinformatics power with hands-on pharma leadership. At NovelusDX she led computational biomarker and early-therapeutics profiling; as VP R&D at Fore Bio and CTO at Wilk, she directed end-to-end pipeline strategy. Her data-driven approach consistently accelerates drug discovery and development.
Seminars
Tuesday 28th April 2026
Transforming GPCR Discovery with AI-Driven Feedback Loops to Deliver Faster, More Reliable & Experimentally Confirmed Therapeutic Candidates
1:15 pm
- Accelerating GPCR discovery with an AI-driven feedback loop delivers reliable therapeutic candidates from in silico to clinic within two years
- Naturalizing de novo peptides with AI tools creates natural analogues that retain function and improve developability
- Demonstrating an end-to-end case study shows how this AI workflow advances GPCR therapeutics rapidly to first-in-human trials
Tuesday 28th April 2026
Panel Discussion: From Static Pictures to Intelligent Pipelines – The Next Era of AI-Driven GPCR Discovery
11:15 am
- How can dynamic modeling, data integration, and cross-disciplinary collaboration be connected to create a truly cohesive GPCR discovery ecosystem?
- What operational barriers must be overcome to achieve genuine AI-enabled translational science across academia and industry?
- What does the roadmap look like for structure-guided and AI-assisted GPCR discovery to reshape drug development over the next decade?
